The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation

DSpace/Manakin Repository

The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation

Citable link to this page

 

 
Title: The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation
Author: Neilan, Tomas G; Shah, Ravi Vikram; Abbasi, Siddique Akbar; Farhad, Hoshang; Groarke, John David; Dodson, John; Coelho-Filho, Otavio; McMullan, Ciaran Joseph; Heydari, Bobak; Michaud, Gregory F.; John, Roy Mattathu; van der Geest, Rob; Steigner, Michael L.; Blankstein, Ron; Jerosch-Herold, Michael; Kwong, Raymond Yan-Kit

Note: Order does not necessarily reflect citation order of authors.

Citation: Neilan, Tomas G., Ravi V. Shah, Siddique A. Abbasi, Hoshang Farhad, John D. Groarke, John A. Dodson, Otavio Coelho-Filho, et al. 2013. “The Incidence, Pattern, and Prognostic Value of Left Ventricular Myocardial Scar by Late Gadolinium Enhancement in Patients With Atrial Fibrillation.” Journal of the American College of Cardiology 62 (23) (December): 2205–2214. doi:10.1016/j.jacc.2013.07.067.
Full Text & Related Files:
Abstract: Objectives

We aimed to identify the frequency, pattern, and prognostic significance of left ventricular (LV) late gadolinium enhancement (LGE) in patients with atrial fibrillation (AF).

Background

There are limited data on the presence, pattern, and prognostic significance of LV myocardial fibrosis in patients with AF. Late gadolinium enhancement during cardiac magnetic resonance (CMR) is a marker for myocardial fibrosis.

Methods

We studied a consecutive group of 664 patients without known prior myocardial infarction being referred for radiofrequency ablation of AF. CMR was requested to assess pulmonary venous anatomy.

Results

Overall, 73% were male, with an average age of 56 years, and an ejection fraction of 55±10%. Left ventricular LGE was found in 88 patients (13%). The endpoint was all-cause mortality, and in this cohort we observed 68 deaths over a median follow-up period of 42 months. On univariable analysis, age (HR 1.05, CI 1.03–1.08, LRχ2 15.2, p=0.0001), diabetes (HR 2.39, CI 1.41–4.09, LRχ210.3, p=0.001), a history of heart failure (HR 1.78, CI 1.09–2.91, LRχ2 5.37, p=0.02), left atrial dimension (HR 1.04, CI 1.01–1.08, LRχ2 6.47, p=0.01), presence of LGE (HR 5.08, CI 3.08–8.36, LRχ2 28.8, p<0.0001), and LGE extent (HR 1.15, CI 1.10–1.21, LRχ2 35.6, p<0.0001) provided the strongest association with mortality. The mortality rate was 8.1% per patient-years in patients with LGE vs. 2.3% patients without LGE. In the best overall multivariable model for mortality, age and the extent of LGE were independent predictors of mortality. Indeed, each 1% increase in LGE associated with a 15% increased risk of death.

Conclusions

In patients with AF, LV LGE is a frequent finding and is a powerful predictor of mortality.
Published Version: 10.1016/j.jacc.2013.07.067
Other Sources: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908872/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:32415190
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters